期刊文献+

替加环素相关不良反应分析 被引量:2

Analysis of Tigecycline-Associated Adverse Reaction
下载PDF
导出
摘要 近年,随着临床多重耐药菌的问题越来越严峻,替加环素的使用越来越受到临床医生的重视。替加环素因独特的抗菌机制,使其对革兰阳性、革兰阴性需氧菌,厌氧菌,特别是泛耐药致病菌均具有非常高的活性,临床主要用于治疗成年患者复杂皮肤、软组织感染、复杂腹腔内感染,社区获得性肺炎,以及泛耐药鲍曼不动杆菌所致的院内获得性肺炎。替加环素的常见不良反应为腹泻、恶心、呕吐等胃肠道反应,一般可耐受,但其严重不良反应,使其最大抗菌效应得不到很好的发挥,限制了重症患者的进一步救治,文章通过分析替加环素各种不良反应,希望可以减少临床不良事件的发生。 In recent years, the problem about multiple drugresistant bacteria has been more and more serious, so tigecycline were being used more and more frequently. Because of the unique antibacterial mechanism, tigecycline has a very high activity in gram-positive and gram-negative aerobic bacteria, anaerobic bacteria, especially extensive drug-resistant pathogens. It mainly used in the treatment of adult patients with complicated skin and soft tissue infections, complicated intra-abdominal infections, communityacquired pneumonia, and nosocomial acquired pneumonia caused by acinetobacter baumannii. The common adverse reactions of tigecycline are gastrointestinal reactions such as diarrhea, nausea and vomiting, which are generally tolerable. Due to the severe adverse reactions, not only its maximum effect but also the further treatment of critically ill patients is limited. The aim of this article is to analyze all kinds of adverse reactions about tigecycline, hoping it can reduce the occurrence of clinical adverse events.
作者 宋淑萍 苏伟 郭丰 徐秋萍 SONG Shuping;SU Wei;GUO Feng;XU Qiuping(Department of CriticalCare Medicine, Sir Run Run Shaw Hospital, School of Medicine, ZhejiangUniversity, Hangzhou Zhejiang 310016, China)
出处 《中国继续医学教育》 2019年第26期131-133,共3页 China Continuing Medical Education
基金 浙江省自然科学基金面上项目(Y15H150007)
关键词 替加环素 四环素类 抗菌药物 多重耐药菌 不良反应 综述 tigecycline tetracycline antimicrobial agents multidrugresistant bacteria adverse reaction review
  • 相关文献

参考文献10

二级参考文献128

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:241
  • 2王兰,王红梅,张建龙,卡米拉,孙湛.大鼠肝缺血再灌注损伤肝核因子-κB、髓过氧化物酶、组织因子与凝血功能紊乱[J].中华肝脏病杂志,2005,13(8):607-608. 被引量:3
  • 3Petersen PJ,Brad ford PA, Weiss WJ,et al. In vitro and in vfi)o activ- ities of tigecycline ( GAR-936 ), daptomycin, and comparative antimi- crobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant grampositive pathogens [ J ]. Antimicrob Agents Chemother ,2002,46 ( 8 ) : 2595-2601.
  • 4Zhanel GG, Karlowsky JA, Rubinstein E, et al. Tigecycline : a novel glycylcycline antibiotic[ J]. Expert Rev Anti Infect Ther,2006, 4( 1 ) : 9-25.
  • 5Guay DR. Oritavancin and tigeeyeline: investigationalantimierobials for multidrug-resistant bacteria[ J]. Pharmacotherapy, 2004,24 ( 1 ) : 58-68.
  • 6Tanaseanu C, Milutinovic S, Calistru PI, et al. Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia [J]. BMC Pulm Med ,2009 ,9 :44.
  • 7ZHAO Yu-zheng, L Pei-de(赵玉珍, 吕佩德). Chinese Journal of Analysis Laboratory(分析试验室), 1997, 16(6): 25.
  • 8SUN Zhen-hua, LI Bing, SUN Da-hai, ZHANG Zhi-gang, YING Hai, GU Sheng, WANG Xiao-ru(孙振华, 李冰, 孙大海, 张志刚, 应海, 谷胜, 王小如). Spectroscopy and Spectral Analysis(光谱学与光谱分析), 2001, 21(1): 57.
  • 9WANG Chun-mei, ZHU Lian-qing, ZHANG Shu-zheng, L Qiong, WANG Jin-gang(王春梅, 褚连青, 张淑珍, 吕琼, 王金钢). Chinese Journal of Rare Metal(稀有金属), 1999, (2): 159.
  • 10LIFei(李飞).Chinese Journal of Rare Earth(稀土),1999,20(2):63-63.

共引文献936

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部